nivolumab
Showing 1 - 25 of 806
Melanoma Trial in Rotterdam (Nivolumab)
Recruiting
- Melanoma
- Nivolumab
-
Rotterdam, Pending, NetherlandsErasmus MC
Oct 30, 2023
Melanoma Trial (ABP 206, Nivolumab)
Not yet recruiting
- Melanoma
- ABP 206
- Nivolumab
- (no location specified)
Sep 20, 2023
Acute Anterior ST Segment Elevation Myocardial Infarction Trial (Nivolumab, Placebo)
Not yet recruiting
- Acute Anterior ST Segment Elevation Myocardial Infarction
- Nivolumab
- Placebo
- (no location specified)
Jun 6, 2023
Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)
Not yet recruiting
- Renal Cell Carcinoma
- Tivozanib
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Sep 19, 2023
Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)
Not yet recruiting
- Melanoma (Skin)
- BMS-986213 (Relatlimab-Nivolumab FDC)
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)
Not yet recruiting
- Melanoma Stage IV
- +3 more
- nivolumab
- (no location specified)
Dec 14, 2022
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Dec 7, 2022
RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)
Not yet recruiting
- RCC
- Renal Cell Carcinoma
- Cabozantinib 80 MG
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Jul 3, 2023
Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,
Recruiting
- Metastatic Gastric Cancer
- +2 more
- Nivolumab
- +2 more
-
New York, New YorkBureau for Cancer Research
May 10, 2023
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial
Not yet recruiting
- Metastatic Nasopharyngeal Carcinoma
- +2 more
- Nivolumab
- +5 more
- (no location specified)
Aug 21, 2023
Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)
Recruiting
- Melanoma
- Metastatic Melanoma
- CDX-301
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 12, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)
Not yet recruiting
- Metastatic Renal Cell Carcinoma
- Axitinib
- Nivolumab
-
Brescia, Italy
- +22 more
Apr 19, 2023
Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023
Pancreatic Cancer Trial in Herlev (drug, radiation, biological)
Not yet recruiting
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Feb 8, 2023
Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)
Terminated
- Hepatocellular Carcinoma
- Abemaciclib
- Nivolumab
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 17, 2022
Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)
Recruiting
- Metastatic Melanoma
- Metastasis to Brain
- Nivolumab
- +3 more
-
Tampa, Florida
- +1 more
Jan 30, 2023
Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)
Not yet recruiting
- Hodgkin Lymphoma
- Axatilimab
- Nivolumab
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Feb 1, 2023
Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
- Nivolumab
- +2 more
-
Tampa, Florida
- +1 more
Nov 11, 2022
Hodgkin Lymphoma Trial in Moscow (Nivolumab)
Recruiting
- Hodgkin Lymphoma
- Nivolumab
-
Moscow, Russian FederationNational Research Center for Hematology
Dec 13, 2022
IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)
Not yet recruiting
- IDH1-mutant Cholangiocarcinoma
- Ivosidenib
- +3 more
- (no location specified)
Jun 29, 2023
Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)
Not yet recruiting
- Endometrial Neoplasms
- Endometrial Cancer
- Nivolumab
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Mar 21, 2023